Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis. - Wikidata - awgldk - TriplyDB

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.

http://www.wikidata.org/entity/Q46157365

about

Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging Sodium channel β subunits: emerging targets in channelopathies Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.A proteomic approach for the diagnosis of bacterial meningitis Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis.Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study.Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants.The proteomic toolbox for studying cerebrospinal fluid.Molecular biomarkers of neurodegeneration.Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis.Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid.Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity.Amyloid-β Homeostasis Bridges Inflammation, Synaptic Plasticity Deficits and Cognitive Dysfunction in Multiple Sclerosis.Voltage-Gated Sodium Channel β Subunits and Their Related Diseases.Voltage-gated sodium channel β subunits: The power outside the pore in brain development and disease.Clinical use of cerebrospinal fluid biomarkers in Alzheimer's disease.CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease.Cerebrospinal fluid levels of soluble amyloid precursor protein and β-amyloid 42 in patients with multiple sclerosis, neuromyelitis optica and clinically isolated syndrome.Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis.Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections.

P2860

Q26750249-17411F01-9519-453B-B603-D31EDD3B4EF7 Q28082122-766EB100-3A9C-4315-945B-86F292B64FAD Q33520347-C076BA3C-79B8-4A21-AA92-4393B4887BF8 Q33553299-AD3EA02F-B68B-49E1-BEDA-CD7F339F837F Q33612995-B43B9293-E716-4EFB-98CC-5B5B22521B0E Q34661859-1DA53E7E-110B-45F5-92E3-E948738CD4A8 Q35008855-6F2304A4-A79D-4185-AF5F-8BB040590C05 Q35119389-09227B36-E246-48B4-8AE7-78F196A5C219 Q37350716-0360E81D-5D56-41EC-B2E2-53BB5ECB0A94 Q37652424-73C3370D-9D82-4813-AA06-8B3C91739CB4 Q37664735-E2F5DF8D-5776-491C-AF11-D96C19458532 Q37998531-0D7C05B8-E936-4FD0-A3C3-2AE23872006D Q38154930-8AB2B3C6-A94D-4BE2-9C62-524219DA4121 Q38782456-2B85336A-C693-4AAD-BE4E-E8BDE2382478 Q41907099-9BFCDB3E-84F3-48B1-80F3-4DBF45027DC9 Q46045880-5F51531C-E95F-44BA-A5DF-B64AB6AB8227 Q47117780-A2AFC908-C37C-4FFD-8038-1FED34C14AA0 Q47720312-5B2F5119-7CE6-4725-8CBB-F4BD457D6CB1 Q47776524-CA9890E9-1244-4862-954C-699B8E043D01 Q48400950-8DE59CAA-4769-4049-89A0-0DF45906E84C Q48474028-D1D7B054-3CB6-455E-8185-A5FCBE20861B Q48650878-0F549D6E-B13A-4F72-95CD-87B33582DA3D Q48684415-C9476183-170C-41B3-9A48-7A8F6E147FBC Q49161820-6A3FD6B8-7FBD-40B7-8E83-7340847CFC65 Q53333738-9A1AFD12-E0BB-43EC-9AB6-69ECBEE35F20

P2860

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.

http://www.wikidata.org/entity/Q46157365

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.

@en

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.

@nl

type

label

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.

@en

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.

@nl

prefLabel

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.

@en

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.

@nl

P1433

Q46157365-D7780B67-95F9-4A95-9E08-0B50A914ED06

P1476

Q46157365-0ED53604-94C2-4084-B0D0-98136F93F384

P2093

Q46157365-060C2F79-B5D7-438E-B9DC-914C9CF5523D

Q46157365-3934B194-02C0-4567-967C-5B4FBE29337C

Q46157365-3C157568-E52D-4213-A35C-AF7A5722E64D

Q46157365-3CB4BCE7-C9EA-4C12-9C61-4006DA4BAB67

Q46157365-43CBE2BB-DE97-47D1-AC28-D07660156EDC

Q46157365-4D79BBEC-BB54-4095-BC82-2F8851709126

Q46157365-6E5E82BE-FE4E-4069-9E96-CDE7F5A497C2

Q46157365-815D54E7-D9C3-460D-81AF-E90E443C3EBC

Q46157365-A91EDA63-9E14-4271-BFEB-677CF070E782

Q46157365-D0A70F94-F244-4600-B95E-1671EB4693CD

P2860

Q46157365-064C2BF4-7059-4B8F-BAE4-47D8EC6200E0

Q46157365-07CCA23A-E9F5-442E-B9DB-B704ED419608

Q46157365-13207237-595A-41AD-8CFD-70C8614BFFBD

Q46157365-1AA2DF8F-13DE-4827-9774-C7AAF8DD33D9

Q46157365-1DA346E0-8B91-419B-96D0-B20D68ECB3AB

Q46157365-2B03E7EA-41D9-47FA-854D-A9FF920991FD

Q46157365-2DD64E63-E658-4AB8-9E8A-E77BC02C3481

Q46157365-343D4247-7DDC-4C8C-9F22-3F496A860759

Q46157365-36714DC3-12CA-47C0-B283-53CED113FC6D

Q46157365-3E1C8F5B-E13C-4735-A3D8-C2611DD0B731

P304

Q46157365-DC67EE6D-9DCC-403F-B9ED-120F70B471E2

P31

Q46157365-C5AFAE3B-06F2-49B7-B63A-A818627E6020

P356

Q46157365-646124A3-3C26-4A20-B099-919B5F243B3D

P433

Q46157365-73477898-AB99-4E4A-8C5F-995AABF2FBD4

P478

Q46157365-5B546A34-0789-4F81-B2BC-95646536D63E

P50

Q46157365-02803FFE-C472-4D3D-AB8B-2E58C3B291F8

Q46157365-B00409ED-2337-4677-AA91-3A07F3402099

Q46157365-B25D6988-BE94-4BCE-A69F-B29856091855

Q46157365-DD54825B-647C-464B-B929-37F97B30F61B

Q46157365-FF4BC50E-CC67-4504-B284-BD9B7C7A36E4

P577

Q46157365-A9988F30-AABE-4FA6-AF29-30133CF2074C

P5875

Q46157365-CAA41804-7491-4027-92A1-A02ED0A2E081

P698

Q46157365-EDD05125-EF79-44F0-A303-D5D5E9AC43D4

P921

Q46157365-2F9631C0-6C4E-4351-979F-1F8BC439A69F

Q46157365-662D500F-66BB-4BD1-B51B-A95AA3B598B4

P356

1352458508100031

P1433

Multiple Sclerosis Journal

P1476

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.

@en

P2093

A Gundersen

http://www.w3.org/2001/XMLSchema#string

A J Simon

http://www.w3.org/2001/XMLSchema#string

A Tarkowski

http://www.w3.org/2001/XMLSchema#string

A Wallin

http://www.w3.org/2001/XMLSchema#string

E Trysberg

http://www.w3.org/2001/XMLSchema#string

G Wu

http://www.w3.org/2001/XMLSchema#string

J Lycke

http://www.w3.org/2001/XMLSchema#string

L Johnsen

http://www.w3.org/2001/XMLSchema#string

M Axelsson

http://www.w3.org/2001/XMLSchema#string

O Andersen

http://www.w3.org/2001/XMLSchema#string

P2860

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity

Purification and cloning of amyloid precursor protein beta-secretase from human brain

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics

Type III neuregulin-1 promotes oligodendrocyte myelination

Control of peripheral nerve myelination by the beta-secretase BACE1

Axonal neuregulin-1 regulates myelin sheath thickness

Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

P304

448-454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1352458508100031

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Anckarsäter

Clas Malmeström

Niklas Mattsson

Henrik Zetterberg

P577

2009-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23800888

http://www.w3.org/2001/XMLSchema#string

P698

19153172

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

multiple sclerosis